[go: up one dir, main page]

GB1508770A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1508770A
GB1508770A GB14265/74A GB1426574A GB1508770A GB 1508770 A GB1508770 A GB 1508770A GB 14265/74 A GB14265/74 A GB 14265/74A GB 1426574 A GB1426574 A GB 1426574A GB 1508770 A GB1508770 A GB 1508770A
Authority
GB
United Kingdom
Prior art keywords
digoxin
pharmaceutical compositions
digitoxin
acetyl
cardiotonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14265/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent UK Swindon Encaps Ltd
Original Assignee
Catalent UK Swindon Encaps Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent UK Swindon Encaps Ltd filed Critical Catalent UK Swindon Encaps Ltd
Priority to GB14265/74A priority Critical patent/GB1508770A/en
Priority to SE7503592A priority patent/SE408687B/en
Priority to DE19752513601 priority patent/DE2513601A1/en
Priority to BE154915A priority patent/BE827349A/en
Priority to DK138675AA priority patent/DK137436B/en
Priority to FI750964A priority patent/FI63671C/en
Priority to CA223,484A priority patent/CA1046410A/en
Priority to NL7503881A priority patent/NL7503881A/en
Priority to JP3968275A priority patent/JPS5644045B2/ja
Priority to AU79663/75A priority patent/AU500001B2/en
Priority to FR7510180A priority patent/FR2265353B1/fr
Priority to AT244575A priority patent/AT342777B/en
Publication of GB1508770A publication Critical patent/GB1508770A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1508770 Pharmaceutical compositions R P SCHERER Ltd 20 March 1975 [1 April 1974] 14265/74 Heading A5B Cardiotonic dosage unit forms comprise soft gelatine capsules containing a liquid cardiotonic composition comprising (a) a cardiac glycoside; (b) dimethyl formamide or dimethyl acetamide; and (c) a liquid polyethylene glycol and optionally propylene glycol or glycerin. The cardiac glycoside may be digoxin, digitoxin, digitalin, lanatoside C, acetyl digitoxin, acetyl digoxin or methyl digoxin.
GB14265/74A 1974-04-01 1974-04-01 Pharmaceutical compositions Expired GB1508770A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB14265/74A GB1508770A (en) 1974-04-01 1974-04-01 Pharmaceutical compositions
SE7503592A SE408687B (en) 1974-04-01 1975-03-27 PROCEDURE FOR MAKING A CARDIOTONIC DOSAGE UNIT CONTAINING A SOFT GELATINE CAPSULA, WHICH IS MADE TO CONTAIN A LIQUID CARDIOTONIC COMPOSITION INCLUDING A HEART GLYLICOLIC
DE19752513601 DE2513601A1 (en) 1974-04-01 1975-03-27 PHARMACEUTICAL PREPARATIONS
BE154915A BE827349A (en) 1974-04-01 1975-03-28 CARDIOTONIC UNIT DOSAGE FORMS INCLUDING A GELATIN CAPSULE CONTAINING A LIQUID CARDIOTONIC COMPOSITION
DK138675AA DK137436B (en) 1974-04-01 1975-04-01 Carrier medium for a heart-strengthening glycoside.
FI750964A FI63671C (en) 1974-04-01 1975-04-01 FOERFARANDE FOER BILDANDE AV EN DOSERINGSENHETSFORM AV EN HJAERTMEDICIN
CA223,484A CA1046410A (en) 1974-04-01 1975-04-01 Cardiotonic composition
NL7503881A NL7503881A (en) 1974-04-01 1975-04-01 DOSAGE UNIT FOR A PHARMACEUTICAL PREPARATION.
JP3968275A JPS5644045B2 (en) 1974-04-01 1975-04-01
AU79663/75A AU500001B2 (en) 1974-04-01 1975-04-01 Cardiac glycoside compositions
FR7510180A FR2265353B1 (en) 1974-04-01 1975-04-01
AT244575A AT342777B (en) 1974-04-01 1975-04-01 METHOD OF MANUFACTURING A HEART REPLACEMENT DOSING UNIT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB14265/74A GB1508770A (en) 1974-04-01 1974-04-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1508770A true GB1508770A (en) 1978-04-26

Family

ID=10038031

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14265/74A Expired GB1508770A (en) 1974-04-01 1974-04-01 Pharmaceutical compositions

Country Status (12)

Country Link
JP (1) JPS5644045B2 (en)
AT (1) AT342777B (en)
AU (1) AU500001B2 (en)
BE (1) BE827349A (en)
CA (1) CA1046410A (en)
DE (1) DE2513601A1 (en)
DK (1) DK137436B (en)
FI (1) FI63671C (en)
FR (1) FR2265353B1 (en)
GB (1) GB1508770A (en)
NL (1) NL7503881A (en)
SE (1) SE408687B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555132B1 (en) 1993-09-28 2003-04-29 Novartis Ag Soft gelatin capsule manufacture

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380030A1 (en) * 1977-02-09 1978-09-08 Christiaens Sa A Liquid and solid solns. of gitoxin - with high bio:availability for treating cardiac disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions
CA1096307A (en) * 1974-02-22 1981-02-24 Elvin A. Holstius Pharmaceutical preparations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555132B1 (en) 1993-09-28 2003-04-29 Novartis Ag Soft gelatin capsule manufacture
US7078054B2 (en) 1993-09-28 2006-07-18 Novartis Ag Soft gelatin capsule manufacture

Also Published As

Publication number Publication date
DE2513601A1 (en) 1975-10-02
DK137436C (en) 1978-08-21
DE2513601C2 (en) 1988-05-26
FR2265353A1 (en) 1975-10-24
NL7503881A (en) 1975-10-03
DK137436B (en) 1978-03-06
FI63671C (en) 1983-08-10
AT342777B (en) 1978-04-25
AU500001B2 (en) 1979-05-10
AU7966375A (en) 1976-10-07
BE827349A (en) 1975-09-29
FR2265353B1 (en) 1980-02-15
FI750964A7 (en) 1975-10-02
DK138675A (en) 1975-10-02
SE7503592L (en) 1975-10-02
FI63671B (en) 1983-04-29
JPS517117A (en) 1976-01-21
ATA244575A (en) 1977-08-15
SE408687B (en) 1979-07-02
CA1046410A (en) 1979-01-16
JPS5644045B2 (en) 1981-10-16

Similar Documents

Publication Publication Date Title
IL40448A (en) Bis-imidazolium(or benzimidazolium)salts,their preparation and pharmaceutical compositions containing them
CA969474A (en) Rumen stable medicament and/or nutrient compositions
ATE17725T1 (en) ANTI-INFLAMMATORY ACTIVE 5-SUBSTITUTE-2,3DIARYL-THIOPHENE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AU461863B2 (en) Propanolamine derivatives, their preparation and therapeutic compositions containing thesame
IL39110A (en) Sulphamides,their preparation and pharmaceutical compositions containing them
IL48061A (en) 4a-phenyl-cis-decahydroisoquinoline derivatives, their preparation and pharmaceutical compositions containing them
SE7506766L (en) MACROMOLECULAR ADENIN DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THE SAME.
NL7513746A (en) (BETA) -LACTAM ANTIBIOTICS, METHODS OF PREPARATION AND USE AS MEDICINAL PRODUCTS.
IL39392A0 (en) Aminopyridazine derivatives,their preparation and pharmaceutical compositions containing them
SE7409203L (en)
IL48678A0 (en) N-(2-pyrrolidinylmethyl)-2-methoxybenzamide derivatives,their preparation and pharmaceutical compositions containing them
GB1508770A (en) Pharmaceutical compositions
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
NO146711C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF OLEANDOMYCIN AND ERYTHROMYCIN DERIVATIVES.
SE420919B (en) PROCEDURE FOR THE PREPARATION OF N? 722-DANSYL-L-ARGIN INGREDIENTS AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
IL47196A (en) 7-substituted-8-aminomethyl-isoflavone derivatives, their preparation and pharmaceutical compositions containing them
IL58648A0 (en) 7-chloro-3-alkoxycarbonyl-5-haolophenyl-2-oxo-2,3-dihydro-1,4-benzo-diazepine derivatives their preparation and pharmaceutical compositions containing them
SE7903554L (en) NEW ISOKINOLIN DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
CA871155A (en) Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
IL48526A (en) 1-imidazolyl-1-phenoxy-3,3-butan-2-one(ol)derivatives,their preparation and pharmaceutical compositions containing them
IL47522A0 (en) Ergopeptine derivatives,their preparation and pharmaceutical compositions containing them
FI793848A7 (en) Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
JPS5331646A (en) Prostane derivatives preparation thereof and pharmaceutical and veterinary active agent containing same

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee